A detailed history of Exchange Traded Concepts, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 9,201 shares of SNDX stock, worth $145,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,201
Previous 9,595 4.11%
Holding current value
$145,651
Previous $196,000 9.69%
% of portfolio
0.0%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$17.93 - $24.81 $7,064 - $9,775
-394 Reduced 4.11%
9,201 $177,000
Q2 2024

Aug 13, 2024

SELL
$18.82 - $23.79 $56,177 - $71,013
-2,985 Reduced 23.73%
9,595 $196,000
Q1 2024

Apr 15, 2024

BUY
$19.71 - $24.57 $88,773 - $110,663
4,504 Added 55.77%
12,580 $299,000
Q4 2023

Jan 05, 2024

BUY
$11.39 - $21.67 $23,326 - $44,380
2,048 Added 33.97%
8,076 $174,000
Q3 2023

Oct 18, 2023

SELL
$14.52 - $21.77 $17,206 - $25,797
-1,185 Reduced 16.43%
6,028 $87,000
Q2 2023

Jul 20, 2023

BUY
$19.35 - $22.31 $122,969 - $141,780
6,355 Added 740.68%
7,213 $150,000
Q1 2023

Apr 12, 2023

BUY
$20.66 - $28.98 $17,726 - $24,864
858 New
858 $18,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $895M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.